250 related articles for article (PubMed ID: 1417380)
21. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Becker KM; Rose JE; Albino AP
Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
[TBL] [Abstract][Full Text] [Related]
23. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
[TBL] [Abstract][Full Text] [Related]
24. Treatment of adolescent smokers with the nicotine patch.
Hanson K; Allen S; Jensen S; Hatsukami D
Nicotine Tob Res; 2003 Aug; 5(4):515-26. PubMed ID: 12959789
[TBL] [Abstract][Full Text] [Related]
25. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
26. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
[TBL] [Abstract][Full Text] [Related]
27. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
28. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
29. Smoking behavior on the first day of a quit attempt predicts long-term abstinence.
Westman EC; Behm FM; Simel DL; Rose JE
Arch Intern Med; 1997 Feb; 157(3):335-40. PubMed ID: 9040302
[TBL] [Abstract][Full Text] [Related]
30. Randomized, controlled trial of transdermal clonidine for smoking cessation.
Hilleman DE; Mohiuddin SM; Delcore MG; Lucas BD
Ann Pharmacother; 1993 Sep; 27(9):1025-8. PubMed ID: 8219431
[TBL] [Abstract][Full Text] [Related]
31. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
[TBL] [Abstract][Full Text] [Related]
32. Varying nicotine patch dose and type of smoking cessation counseling.
Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
[TBL] [Abstract][Full Text] [Related]
33. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
Joseph AM; Norman SM; Ferry LH; Prochazka AV; Westman EC; Steele BG; Sherman SE; Cleveland M; Antonuccio DO; Hartman N; McGovern PG
N Engl J Med; 1996 Dec; 335(24):1792-8. PubMed ID: 8943160
[TBL] [Abstract][Full Text] [Related]
34. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
[TBL] [Abstract][Full Text] [Related]
35. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
Anthenelli RM; Blom TJ; McElroy SL; Keck PE
Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
[TBL] [Abstract][Full Text] [Related]
36. A placebo-controlled study of three clonidine doses for smoking cessation.
Gourlay S; Forbes A; Marriner T; Kutin J; McNeil J
Clin Pharmacol Ther; 1994 Jan; 55(1):64-9. PubMed ID: 8299319
[TBL] [Abstract][Full Text] [Related]
37. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
[TBL] [Abstract][Full Text] [Related]
38. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
[TBL] [Abstract][Full Text] [Related]
39. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
[TBL] [Abstract][Full Text] [Related]
40. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.
Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; Rennard SI
Arch Intern Med; 1991 Apr; 151(4):749-52. PubMed ID: 2012458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
